Affiliation:
1. A.M. Granov Russian Research Center of Radiology and Surgical Technologies
Abstract
This review summarizes the literature data about hepatic artery infusion chemotherapy in the treatment of advanced hepatocellular carcinoma. This method is safe and effective in tumors of very large volume and also in cases of portal vein tumor thrombosis when other interventional technologies (chemoembolization, radioembolization) are contraindicated or ineffective. Good results are the reasons for inclusion hepatic artery infusion chemotherapy in South-Asia clinical recommendations for the treatment of advanced hepatocellular carcinoma, but this method fails to attend in USA and European guidelines. Arterial infusion chemotherapy looks like non-expensive and technically simple procedure. It’s use in American and European patients including Russiais topical.
Publisher
Non-profit partnership Society of Interventional Oncoradiologists
Reference38 articles.
1. Reig M, Forner A, Rimola J, et al. BCLC strategy for prognostic prediction and treatment recommendation: The 2022 update J Hepatol. 2022;76(3):681-93. DOI: 10.1016/j.jhep.2021.11.018.
2. Breder VV, Laktionov KP. Hepatocellular carcinoma of intermediate stage BCLC B – official recommendations as a strategy of basic treatment and point of counting out in evaluation of efficacy of new approaches. Malignant Tumors. 2016;(4):29-35. URL: https://www.malignanttumors.org/jour/article/view/282
3. Breder VV, Balachnin PV, Virshke ER, et al. Practical recommendations for medical treatment of patients with hepatocellular carcinoma: Practical recommendations RUSSCO #3S2. 202025 Malignant Tumors. 2020;10 (3s2-1):450-69 DOI: 10.18027/2224-5057-2020-10-3s2-25. (in Russian)
4. Cerrito L, Annicchiarico BE, Iezzi R, et al. Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers (review). World J Gastroenterol. 2019;25(31):4360-82. DOI: 10.3748/wjg.v25.i31.4360.
5. Krieg S, Essing T, Krieg A, et al. Recent trends and in-hospital mortality of transarterial chemoembolization (TACE) in Germany:A systematic analysis of hospital discharge data between. 2010 and. 2019. Cancers. 2022;14(9):2088. DOI: 10.3390/cancers14092088.